Skip to main content
Ascletis Pharma Inc. logo

Ascletis Pharma Inc. — Investor Relations & Filings

Ticker · 1672 ISIN · KYG0520K1094 LEI · 254900SKEFCO9I3GPL05 HKEX Manufacturing
Filings indexed 1,475 across all filing types
Latest filing 2016-04-01 Board/Management Inform…
Country KY Cayman Islands
Listing HKEX 1672

About Ascletis Pharma Inc.

http://www.ascletis.com

Ascletis Pharma Inc. is a fully integrated, R&D driven biotechnology company dedicated to the development and commercialization of potential best-in-class and first-in-class therapeutics. The company covers the entire value chain from discovery to sales. Ascletis primarily focuses on metabolic diseases, including chronic weight management, utilizing proprietary platforms such as Artificial Intelligence-assisted Structure-Based Drug Discovery (AISBDD), Ultra-Long-Acting Platform (ULAP), and Peptide Oral Transport ENhancement Technology (POTENT). Key pipeline candidates include ASC30 (oral/subcutaneous GLP-1R agonist), ASC35 (GLP-1R/GIPR dual agonist), ASC36 (amylin receptor agonist), and ASC37 (GLP-1R/GIPR/GCGR triple agonist). The company also maintains active programs in viral diseases, NASH/PBC, and oncology.

Recent filings

Filing Released Lang Actions
ESTABLISHMENT OF THE RISK COMMITTEE
Board/Management Information Classification · 100% confidence The document is an announcement from the board of directors of World Houseware (Holdings) Limited regarding the establishment of a new Risk Committee. It lists the members appointed to this committee and the effective date. There is no financial data, no mention of a report or filing, and the content focuses on board/management structural changes. This fits the category of Board/Management Information (MANG). The document length is short and it is clearly an announcement of a board committee formation, not a report or regulatory filing.
2016-04-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2016
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/3/2016, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised and issued share capital, share options, warrants, convertibles, and other share-related activities. The content is a regulatory filing reporting monthly changes in the company's share capital and securities, typical of a regulatory compliance report rather than a financial report or announcement. It does not contain financial statements, earnings data, or management commentary. It is not an announcement of a report but a detailed regulatory submission. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2016-04-01 English
RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2015
Annual Report Classification · 100% confidence The document is titled "RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2015" and contains detailed audited consolidated financial results, including comprehensive financial statements such as the consolidated statement of profit or loss and other comprehensive income, consolidated statement of financial position, notes to the consolidated financial statements, segment information, and application of new accounting standards. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. The presence of detailed financial data, notes, and segment analysis confirms this is a full annual financial report. The document is not merely an announcement of a report or a certification letter, but the actual annual financial report itself. Therefore, the appropriate classification is Annual Report (10-K). FY 2015
2016-03-18 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 95% confidence The document is a formal announcement from a company listed on the Hong Kong Stock Exchange. It lists the members of the board of directors, their roles, and committee memberships. There is no financial data, no discussion of financial results, no mention of shareholder votes, or any other report content. The document is essentially an announcement of the composition and structure of the board and its committees. This fits the definition of Board/Management Information (MANG), which covers announcements of changes or details about the company's board of directors or senior management. The document length is short (1657 characters), and it is not a report or a notice about a report publication. Therefore, the correct classification is MANG with high confidence.
2016-03-18 English
APPOINTMENT OF EXECUTIVE DIRECTOR
Board/Management Information Classification · 100% confidence The document is an announcement from World Houseware (Holdings) Limited regarding the appointment of Mr. Kwong Bau To as an Executive Director of the company. It details his background, responsibilities, share options, remuneration, and compliance with listing rules. There is no financial data, report, or presentation content. The document is clearly about a change in the company's board of directors. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is under 5,000 characters and is an announcement, not a full report or presentation.
2016-03-18 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is an announcement from the board of directors of World Houseware (Holdings) Limited regarding the date of a board meeting. The meeting will approve the release of the final results for the year ended 31 December 2015 and consider the payment of a final dividend. The document does not contain any financial data or the actual report but only announces the upcoming board meeting and the agenda. The document length is short (1657 characters) and it is clearly an announcement rather than the report itself. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement about the board meeting and upcoming results release, not the Annual Report or Earnings Release itself.
2016-03-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.